Get the Stockscreener App
116.89
1.87%
-2.2706
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $116.89, with a volume of 317.18K.
It is down -1.87% in the last 24 hours and up +0.28% over the past month.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$119.16
Open:
$119.04
24h Volume:
317.18K
Relative Volume:
0.36
Market Cap:
$14.50B
Revenue:
$2.72B
Net Income/Loss:
$254.30M
P/E Ratio:
56.56
EPS:
2.0665
Net Cash Flow:
$564.37M
1W Performance:
-7.29%
1M Performance:
+0.28%
6M Performance:
+1.12%
1Y Performance:
+13.63%
1-Day Range:
$116.63
$119.72
1-Week Range:
$116.63
$126.57
52-Week Range:
$97.31
$129.50
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
116.84 | 14.50B | 2.72B | 254.30M | 564.37M | 2.0665 |
|
TMO
Thermo Fisher Scientific Inc
|
566.83 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
206.90 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
145.18 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
457.67 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
207.18 | 36.97B | 15.32B | 1.41B | 1.96B | 7.62 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
KeyCorp Forecasts Strong Price Appreciation for Revvity (NYSE:RVTY) Stock - MarketBeat
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Trust Point Inc. Purchases Shares of 4,594 Revvity, Inc. (NYSE:RVTY) - MarketBeat
Barclays Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Revvity (NYSE:RVTY) Updates FY 2025 Earnings Guidance - MarketBeat
Jefferies raises Revvity stock price target to $130, maintains Hold - MSN
Revvity anticipates 3%-5% organic growth in 2025 amid market stabilization - MSN
Revvity, Inc. (NYSE:RVTY) Insider Joel S. Goldberg Sells 15,170 Shares - MarketBeat
Revvity’s Strong Recurring Revenue and Growth Prospects Justify Buy Rating - TipRanks
Exchange Traded Concepts LLC Sells 3,502 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Raymond James Adjusts Price Target on Revvity to $145 From $140 -February 03, 2025 at 11:43 am EST - Marketscreener.com
KeyBanc Adjusts Revvity Price Target to $145 From $132 -February 03, 2025 at 11:26 am EST - Marketscreener.com
Revvity (NYSE:RVTY) Receives "Outperform" Rating from Raymond James - MarketBeat
Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say - MSN
Revvity, Inc. (NYSE:RVTY) Q4 2024 Earnings Call Transcript - MSN
Revvity shares leap over 5% as Q4 earnings top estimates - MSN
Revvity (RVTY) Surpasses Q4 Earnings Estimates - MSN
Revvity’s Strong Q4 Performance and 2025 Outlook - TipRanks
Revvity (NYSE:RVTY) Releases Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Earnings call transcript: Revvity Q4 2024 shows steady growth amid mixed market reaction - MSN
Jefferies raises Revvity stock price target to $130, maintains Hold By Investing.com - Investing.com Australia
Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ... - Yahoo Finance
Revvity Reports Positive 2024 Financial Results - TipRanks
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations By Stock Story - Investing.com Canada
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations - Yahoo Finance
RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust - MSN
Revvity's 2025 Guidance Signals Cautious Optimism Amid Slower-Than-Expected Pharma Spending Recovery - Morningstar
Citigroup Raises Price Target on Revvity to $155 From $145 -January 31, 2025 at 02:24 pm EST - Marketscreener.com
Evercore ISI Adjusts Price Target on Revvity to $138 From $125 -January 31, 2025 at 11:35 am EST - Marketscreener.com
Revvity Predicts Lower 2025 Earnings Despite Strong Fourth Quarter - Finimize
Revvity: Q4 Earnings Snapshot - Houston Chronicle
Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending - MSN
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024 - BioSpace
Revvity Inc (RVTY) Q4 2024 Earnings: EPS of $0.78 Beats Estimates, Revenue Hits $729 Million - GuruFocus.com
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.26%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):